Inhibiting NF-κB Signaling Activation Reduces Retinal Neovascularization by Promoting a Polarization Shift in

Abstract

Insights

Blocking Nuclear Factor kappa-light-chain-enhancer of activated B cells (NF-κB) signaling reduces retinal neovascularization (RNV) in mice. This occurs by shifting macrophage polarization from M1 to M2, decreasing inflammation and promoting healing.

Area of Science:

  • Ophthalmology
  • Immunology
  • Molecular Biology

Background:

  • Nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) signaling influences tumor angiogenesis and metastasis.
  • The precise role of NF-κB in retinal neovascularization (RNV) is not fully understood.

Purpose of the Study:

  • To investigate the role and mechanism of NF-κB in regulating RNV.
  • To determine how NF-κB affects macrophage polarization in the context of RNV.

Main Methods:

  • Utilized oxygen-induced retinopathy (OIR) mouse models.
  • Assessed NF-κB signaling activation via immunofluorescence and western blotting.
  • Quantified RNV and macrophage recruitment using retinal flat-mounts.
  • Analyzed macrophage polarization and gene expression through flow cytometry, immunofluorescence, and RT-PCR.

Main Results:

  • NF-κB signaling components (p-IκBα, p-p65) were upregulated in OIR mice.
  • Inhibition of NF-κB with PDTC significantly decreased RNV.
  • PDTC treatment led to decreased M1 macrophages and increased M2 macrophages, with corresponding changes in cytokine expression.

Conclusions:

  • Inhibition of NF-κB signaling effectively reduces RNV in OIR mice.
  • NF-κB blockade promotes the M1 to M2 macrophage polarization shift.
  • This shift in macrophage polarization is a key mechanism by which NF-κB inhibition impacts RNV.